Ori Gutwerg - Aug 23, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP, GENERICS
Signature
/s/ Ori Gutwerg, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Aug 23, 2023
Transactions value $
-$970,851
Form type
4
Date filed
8/25/2023, 04:22 PM
Previous filing
Mar 9, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $425K +13.5K +21.44% $31.49 76.5K Aug 23, 2023 Direct
transaction ANIP Common Stock Sale -$842K -13.5K -17.66% $62.39 63K Aug 23, 2023 Direct F1
transaction ANIP Common Stock Sale -$128K -2.06K -3.27% $62.39 60.9K Aug 23, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise -$425K -13.5K -50% $31.49 13.5K Aug 23, 2023 Common Stock 13.5K $31.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive.
F3 25% of the total options vested on each of February 15, 2022 and February 15, 2023. 25% of the total options will vest on each of February 15, 2024 and February 15, 2025.